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Summary
Objective: Microfracture is used to treat articular cartilage injuries, but leads to the formation of ﬁbrocartilage rather than native hyaline articular
cartilage. Since bone morphogenetic protein 7 (BMP-7) induces cartilage differentiation, we hypothesized that the addition of the morphogen
would improve the repair tissue generated by microfracture. We determined the effects of these two treatments alone and in combination on
the quality and quantity of repair tissue formed in a model of full-thickness articular cartilage injury in adolescent rabbits.
Design: Full-thickness defects were made in the articular cartilage of the patellar grooves of forty, 15-week-old rabbits. Eight animals were
then assigned to (1) no further treatment (control), (2) microfracture, (3) BMP-7, (4) microfracture with BMP-7 in a collagen sponge (combi-
nation treatment), and (5) microfracture with a collagen sponge. Animals were sacriﬁced after 24 weeks at 39 weeks of age. The extent of
healing was quantitated by determining the thickness and the surface area of the repair tissue. The quality of the repair tissue was determined
by grading specimens using the International Cartilage Repair Society Visual Histological Assessment Scale.
Results: Compared to controls, BMP-7 alone increased the amount of repair tissue without affecting the quality of repair tissue. Microfracture
improved both the quantity and surface smoothness of repair tissue. Compared to either single treatment, the combination of microfracture and
BMP-7 increased both the quality and quantity of repair tissue.
Conclusions: Microfracture and BMP-7 act synergistically to stimulate cartilage repair, leading to larger amounts of repair tissue that more
closely resembles native hyaline articular cartilage.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Injuries to articular cartilage are common, frequently lead to
disability, and have a limited ability for self-repair. Lacera-
tions to cartilage that are superﬁcial to the tidemark do not
heal, while injuries that penetrate the subchondral plate
often heal with ﬁbrocartilage1. The lack of repair in the for-
mer case may result from the avascular nature of cartilage,
which prevents access to components of the wound healing
process, including growth factors and progenitor cells. In
contrast, cartilage injuries that penetrate bone lead to
bleeding into the defect and the formation of a ﬁbrin clot.
This clot subsequently remodels into ﬁbrocartilage.
Multiple surgical procedures have been developed to
treat articular cartilage injuries, including marrow-stimulation
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Received 6 July 2005; revision accepted 4 April 2006.1techniques, autologous and allogeneic osteochondral trans-
plantation, autologous chondrocyte implantation, and perios-
teal grafting2. In marrow-stimulation procedures, including
subchondral bone microfracture, Pridie drilling, and abrasion
chondroplasty, the subchondral plate at the base of
a chondral defect is surgically disrupted. This leads to ﬁbrin
clot and subsequent ﬁbrocartilage formation. Microfracture
is the most well-studied marrow-stimulation procedure, and
involves the arthroscopic penetration of the subchondral
plate with an awl. In case series with up to 17 years of fol-
low-up, microfracture has led to durable improvements in
both patient symptoms and function3. Microfracture also
compares favorably with other treatments. In a randomized
controlled trial comparing microfracture with autologous
chondrocyte implantation, both treatments led to short-term
clinical improvement with microfracture leading to a signiﬁ-
cantly better improvement in the Short Form-36 (SF-36)
physical component score4.
Despite these positive clinical results, questions remain
about the quality and durability of the ﬁbrocartilage formed
after microfracture. In animal models of marrow stimulation,
the regenerated cartilage clearly differs from normal articular
cartilage, with increased amounts of type I collagen, altered
tissue architecture, and random orientation of collagen126
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time, with surface ﬁbrillation, loss of hyaline appearance, and
loss of structural integrity6,7. Therefore, the clinical outcomes
of patients undergoing microfracture would likely be im-
proved if more normal repair cartilage were produced.
Application of morphogenetic proteins may be one ap-
proach to enhance the repair tissue generated by microfrac-
ture8,9. With the proper stimulation, themesenchymal cells in
the initial ﬁbrin clot may be induced to assume and maintain
a phenotype that more closely resembles normal articular
cartilage. In particular, both in vitro and in vivo experiments
suggest that bone morphogenetic protein 7 (BMP-7), also
known as osteogenic protein-1, may aid the healing of chon-
dral defects. This morphogen is capable of inducing de novo
cartilage formation andalsoplaysa role in themaintenanceof
articular cartilage. It is found in normal articular cartilage10
and stimulates chondrocyte proliferation, differentiation,
andmetabolism11e16. In addition, otherBMP familymembers
also enhance the metabolism and phenotypic maintenance
of chondrocytes17,18. Finally, intra-articular delivery of BMP-
7 using a mini-osmotic pump enhanced articular cartilage re-
pair in a sheep model of chondral injury19.
These results suggest that microfracture and BMP-7 treat-
ment will synergistically enhance cartilage healing, with
microfracture recruiting stem cells and BMP-7 stimulating
the proliferation and chondrocytic differentiation of these
cells. This may lead to a repair cartilage that is more similar
to normal articular cartilage than the tissue induced by either
treatment alone. Combining the two treatmentsmay also pro-
vide a simple method for localized morphogen/growth factor
delivery within a joint. Growth factor impregnated matrices
can be securely press-ﬁt into the enclosed spaces provided
by microfracture holes. Diffusion of factors would then lead
to high local concentrations within a chondral defect.
We have therefore examined the effects of microfracture
and BMP-7 treatment, alone and in combination, on the
healing of full-thickness articular cartilage lesions in adoles-
cent rabbits.
We sought to address the following four hypotheses:
(1) Microfracture leads to improvement in the quantity and
quality of repair tissue compared with control lesions.
(2) Application of soluble BMP-7 leads to improvement in
the quantity and quality of repair tissue compared with
control lesions.
(3) Microfracture combined with BMP-7 delivered in a col-
lagen sponge (combination treatment) leads to im-
provement in the quantity and quality of repair
tissue compared with microfracture alone.
(4) Microfracture combined with BMP-7 delivered in a col-
lagen sponge (combination treatment) leads to im-
provement in the quantity and quality of repair
tissue compared with the application of soluble
BMP-7 alone.
Method
ANIMAL MODEL
All animal protocols were reviewed and approved by our
Institutional Animal Care and Use Committee. Fifteen-
week-old male New Zealand white rabbits weighing
2.5e3 kg were used in this study. Following intravenous ad-
ministration of adequate anesthesia (50 mg/kg ketamine,
5 mg/kg xylazine, and 0.5 mg/kg acepromazine), a medial
parapatellar skin incision was made in the right knee of
each animal. The incision was extended through the jointcapsule and the patella was subluxated laterally. A 2 mm
by 7 mm full-thickness defect was made in the articular car-
tilage of the trochlear groove using a curette. Care was
taken to minimize disruption of the underlying subchondral
bone, which differed from cartilage in appearance, consis-
tency, and resistance to curetting.
The experiment consisted of the following ﬁve treatment
groups, with eight animals in each group:
Treatment 1 Control defects: no additional treatment.
Treatment 2 Microfracture: Using 18 gauge needles,
two 3 mm deep microfractures were
made through the subchondral bone at
the base of the defect, one proximally
and one distally. Each microfracture hole
was 1.5 mm in diameter and the holes
were separated by 2 mm.
Treatment 3 BMP-7: 10 mg of recombinant human BMP-
7 (Stryker Corporation, Hopkinton, MA) dis-
solved in 10 ml of 5 mM hydrochloric acid
was painted onto the bone at the base of
the chondral lesion and allowed to adsorb
for 5 min.
Treatment 4 Microfracture plus BMP-7 adsorbed onto
a collagen sponge (combination treat-
ment): After microfracture, 10 mg of BMP-
7 dissolved in 10 ml of 5 mM hydrochloric
acid was adsorbed onto a 2 mm diameter
by 3 mm tall cylinder of a type I collagen
sponge (Helistat Sponge, Integra Life-
Sciences, Plainsboro, NJ) for 15 min.
This sponge was then press-ﬁt into the dis-
tal microfracture hole.
Treatment 5 Microfracture plus collagen sponge: Aftermi-
crofracture, a 2 mm diameter by 3 mm tall
cylinder of type I collagen sponge soaked in
10 ml of 5 mM hydrochloric acid was press-
ﬁt into the distal microfracture hole.
Following the above treatments, magniﬁed digital photo-
graphs of the chondral defects were taken [Fig. 1(A)]. The
resolution of these photographs was comparable to the
images seen using a dissecting microscope. The patellae
were reduced and the wounds were closed in two layers
with absorbable sutures. For pain control, the animals re-
ceived 0.1 mg buprenorphine subcutaneously immediately
after surgery and then daily until comfortable. Postoperative
complications were recorded. The animals were not immobi-
lized andwere allowedunrestricted activity in their cagesuntil
sacriﬁce at 24 weeks (39 weeks of age). Gait was observed
prior to sacriﬁce. The patellofemoral joints were then ex-
posed, the chondral defects were photographed [Fig. 1(B)],
and blocks of bone containing the trochlear grooves were ex-
cised. The contralateral, unoperated trochlear grooves were
also harvested from four animals in each treatment group.
As a control for our model and in particular to conﬁrm that
the defects were full-thickness cartilage lesions, chondral de-
fectsweremade in six additional knees. These sampleswere
immediately excised, prepared for histology, and stainedwith
hematoxylin and eosin (H&E) as described below.
QUANTITATION OF TISSUE SURFACE AREA
Photographs of the chondral defects at the time of both sur-
gery and sacriﬁce were analyzed using the Scion Image im-
age-analysis program (Scion Corp., Frederick, MD). A single,
blinded observer made all measurements. The area of the de-
fect at the time of surgery was determined (quantityB in Fig. 2)
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C in Fig. 2). These values were used to calculate the percent-
age of the original defect surface area covered with repair tis-
sue at the time of sacriﬁce as follows (Fig. 2):
Percentage of surface area covered¼ ½ðB CÞ=B  100:
Fig. 1. Gross appearance of a chondral defect. (A) Intraoperative
appearance of a chondral defect. The specimen has been treated
with microfracture and a collagen sponge. The collagen sponge
has been press-ﬁt into the microfracture hole on the right. The ruler
shows millimeter spacing. (B) Appearance of a chondral defect at
sacriﬁce. The lesion shown in (A) has been ﬁlled with two large
areas of repair tissue.
Fig. 2. Calculation of the percentage of the original defect surface
area covered with repair tissue at sacriﬁce. In order to quantitate
the percentage of the original defect surface area covered with re-
pair tissue, photographs were taken of the defects at the time of
surgery (top panel) and sacriﬁce (bottom panel). The surface
areas of the defects at surgery (B) and at sacriﬁce (C ) were quan-
titated and used to calculate the percentage of surface area
covered as shown.HISTOLOGY
The trochlear grooves were ﬁxed for 48 h in 10% neutral
buffered formalin. Samples were then decalciﬁed in 10%
formic acid with 0.2 M sodium citrate. Following extensive
washing in water, 2-mm-thick transverse slices across the
trochlea were made. Two samples from each specimen,
one from the proximal area of the defect and one from the
distal region, were then dehydrated in ethanol, embedded
in parafﬁn, and sectioned at 4 mm. These transverse sec-
tions were then stained with each of the following: (1)
H&E, (2) safranin-O and fast green, (3) a monoclonal anti-
sera against type I collagen (Ab-1; Oncogene Research
Products, Boston, MA) at a 1:100 dilution, and (4) a mono-
clonal antisera against type II collagen (Ab-1; Oncogene
Research Products, Boston, MA) at a 1:100 dilution. Immu-
nostaining was completed using a biotinylated horse anti-
mouse secondary immunoglobulin (Vector, Burlingame,
CA) with the Vectastain ABC-AP reagent and Vector Red
as substrate or with the Vectastain ABC-peroxidase reagent
and diaminobenzidine as substrate (Vector, Burlingame,
CA). Photomicrographs were taken of each tissue region
using the 20 objective. Samples were visualized using
both white and polarized light.
The repair tissue, adjacent normal articular cartilage, and
normal cartilage from the unoperated contralateral knees
were graded using the International Cartilage Repair Soci-
ety (ICRS) Visual Histological Assessment Scale20 by one
blinded observer (Table I). Samples were judged to be hy-
aline if they had a homogenous matrix, abundant safranin-O
staining, abundant type II collagen immunostaining, little or
no type I collagen immunostaining, round cells in lacunae,
and an organized collagen arrangement under polarized
light. Fibrocartilage was deﬁned as a sample with distinct ﬁ-
bers in the matrix, round or elliptical cells with or without
Table I
ICRS Visual Histological Assessment Scale
Feature Score
I. Surface
Smooth/continuous 3
Discontinuities/irregularities 0
II. Matrix
Hyaline 3
Mixture: hyaline/ﬁbrocartilage 2
Fibrocartilage 1
Fibrous tissue 0
III. Cell distribution
Columnar 3
Mixed/columnar-clusters 2
Clusters 1
Individual cells/disorganized 0
IV. Cell population viability
Predominantly viable 3
Partially viable 1
<10% viable 0
V. Subchondral bone
Normal 3
Increased remodeling 2
Bone necrosis/granulation tissue 1
Detached/fracture/callus at base 0
VI. Cartilage mineralization
(calciﬁed cartilage)
Normal 3
Abnormal/inappropriate location 0
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both type I and type II collagen immunostaining, and a dis-
organized collagen arrangement when viewed under pol-
arized light. Mixed tissue was deﬁned as having at least
30% hyaline cartilage, with the remainder being ﬁbrocarti-
lage. Fibrous tissue was deﬁned as having a ﬁbrous matrix
with small, irregularly-shaped cells, little or no safranin-O
staining, little or no type II collagen immunostaining, abun-
dant type I collagen immunostaining, and a disorganized
appearance under polarized light (Fig. 3). Repair tissue
was not present on two sections from the control group
and three sections from the BMP-7 single treatment group.
These specimens were neither graded using the ICRS
scale nor scored for tissue thickness as described below.
QUANTITATION OF TISSUE THICKNESS
Digital images of histology specimens stained with H&E
and/or safranin-O were captured and then analyzed using
the Scion Image image-analysis program. For each slide,
the total area of repair tissue (quantity A, Fig. 4) was mea-
sured as well as the total length of repair tissue (quantity LFig. 4). The average thickness of the repair cartilage was
then deﬁned as A/L. The average thickness of normal artic-
ular cartilage from the same slide was calculated similarly.
In order to normalize these results, the percentage thick-
ness of the repair tissue relative to the control tissue was
calculated as follows:
Percentage thickness¼ ½ðAverage thickness repair tissueÞ
=ðAverage thickness control tissueÞ  100:
All measurements for thickness determination were made
by one blinded observer.
STATISTICAL ANALYSIS
StatView 4.51 (Abacus Concepts, Berkeley, CA) was
used for all statistical analyses. The values for both percent-
age surface area covered and percentage thickness of the
repair tissue were arcsine transformed to approximate a nor-
mal distribution. To test the hypotheses for these continu-
ous variables, analysis of variance and Fisher’s protectedFig. 3. Histological results. Representative specimens of normal, control articular cartilage (combination treatment group), hyaline repair tissue
(combination treatment group), ﬁbrocartilage (microfracture single treatment group), and ﬁbrous repair tissue (control defect group) are shown.
Please see text for a discussion of staining patterns. The specimens in the far left column have been stained with safranin-O and fast green
and visualized with white light. The second column shows type II collagen immunostaining. The third column shows type I collagen immunos-
taining. The specimens in the far right column have been stained with safranin-O and fast green and visualized with polarized light. Scale is as
indicated in the lower right panel (objective, 20).
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niﬁcantly different means among the four planned com-
parisons. These P values were then adjusted upwards by
a sequential Bonferroni procedure to control the family-
wise Type I error rate and reported.
For the categorical variables in the ICRS Histological
Scale (surface, matrix, cell distribution, cell population viabil-
ity, subchondral bone, and cartilage mineralization), contin-
gency tables were analyzed for each hypothesis tested
and Fisher’s exact P with a correction for continuity was
noted. These P values were then adjusted upwards by a se-
quential Bonferroni procedure to control the family-wise
Type I error rate and reported. Although repair tissues
were assessed using four categories for both matrix-type
and cell distribution, it was necessary to group specimens
with scores of 0 and 1 and to group specimens with scores
of 2 and 3 for statistical analysis of the histology results.
Specimens with scores of 2 or 3 were deﬁned as having su-
perior matrix/cell distribution, while specimens with scores of
0 or 1 were deﬁned as having inferior matrix/cell distribution.
Additionally, to assess the role of the collagen sponge
used in the combination treatment, comparisons were
made between the combination treatment (microfracture
with BMP-7 in a collagen sponge) and microfracture with
a collagen sponge alone. Simple t tests were conducted for
percentage surface area covered and percentage thickness
of the repair tissue (arcsine transformed), while contingency
tables were analyzed for the components of the ICRS scale.
Results
To verify that we created full-thickness articular cartilage
defects, six control knees were examined histologically im-
mediately after defect creation. In all six knees, all of the
cartilage was removed except for remnants of calciﬁed car-
tilage that interdigitated with the subchondral bone. There
Fig. 4. Calculation of average tissue thickness. Image analysis of
histology specimens was used to quantitate the average thickness
of both repair tissue and normal adjacent articular cartilage. The to-
tal length of the tissue (L) and the total area of the tissue (dotted
area A) were quantitated and then used to calculate average thick-
ness as shown. Specimens were stained with H&E and viewed us-
ing the 20 objective.was minimal disruption of the underlying subchondral plate
with no penetration of the marrow cavity [Fig. 5(A)]. The car-
tilage of animals at this age has the structure of adult carti-
lage, with a superﬁcial zone, a radial zone, and a calciﬁed
zone with a distinct tidemark [Fig. 5(B)].
All of the experimental animals survived surgery. There
were no postoperative complications. All animals ambu-
lated normally prior to sacriﬁce at 24 weeks. On gross ex-
amination at the time of sacriﬁce, defects were ﬁlled with
variable amounts of tissue similar in color, consistency,
and height to the surrounding normal cartilage [Fig. 1(B)].
The histology results varied widely, with repair tissue rang-
ing from organized hyaline tissue to disorganized ﬁbrous tis-
sue (Fig. 3). The undamaged articular cartilage surrounding
the repair tissue was histologically identical to normal artic-
ular cartilage from the contralateral control knees with
similar safranin-O staining (data not shown).
There were no differences among the treatment groups in
the ICRS categories of cell population viability (all samples
scored as 3, predominantly viable), subchondral bone (all
samples scored as 3, normal), and cartilage mineralization
(all samples scored as 3, normal). The results for each
treatment for percentage surface area covered, percentage
thickness of the repair tissue, and the ICRS categories of
surface, matrix, and cell distribution are shown in
Figs. 6e10.
Fig. 5. Histological appearance of a chondral defect immediately
after creation. (A) Low power (objective, 2.5). (B) High power
(objective, 10). Scale is as indicated.
1131Osteoarthritis and Cartilage Vol. 14, No. 11Fig. 6. Comparison of microfracture with controls (hypothesis 1). Comparison of the microfracture single treatment group and the control defect
group for percentage surface area covered, percentage thickness, percentage of specimens with smooth surface (ICRS 3), percentage of
specimens with superior matrix (ICRS 2 and 3), and percentage of specimens with superior cell distribution (ICRS 2 and 3). *Indicates
P< 0.05; ***indicates P< 0.001.MICROFRACTURE VS CONTROL (HYPOTHESIS 1)
Compared to controls, microfracture resulted in a statisti-
cally signiﬁcant improvement in both the amount and surface
smoothness of the repair tissue. There was an increase in
percentage surface area covered compared with control de-
fects (50% vs 13%, P< 0.0003) as well as percentage thick-
ness (61%vs34%,P¼ 0.0005). Themicrofracture grouphad
a signiﬁcantly greater proportion of samples with a smooth
surface (ICRS score 3) than the control group (69% vs
21%, P¼ 0.041). There were not signiﬁcant differences inthepercentageof specimenswith either superiormatrix or su-
perior cell distribution (Fig. 6).
BMP-7 VS CONTROL (HYPOTHESIS 2)
Compared to controls, BMP-7 resulted in a statistically
signiﬁcant increase in the amount of repair tissue without
affecting the quality of the repair tissue. There was an in-
crease in the percentage surface area covered compared
with the control group (31% vs 13%, P< 0.0004), but not
percentage thickness (34% vs 34%, NS). There was a trendFig. 7. Comparison of BMP-7 with controls (hypothesis 2). Comparison of the BMP-7 single treatment group and the control defect group for
percentage surface area covered, percentage thickness, percentage of specimens with smooth surface (ICRS 3), percentage of specimens
with superior matrix (ICRS 2 and 3), and percentage of specimens with superior cell distribution (ICRS 2 and 3). ***Indicates P< 0.001.
1132 A. C. Kuo et al.: Microfracture and BMP-7Fig. 8. Comparison of the combination treatment with microfracture (hypothesis 3). Comparison of the combination treatment group (micro-
fracture with BMP-7 in a collagen sponge) with the microfracture single treatment group for percentage surface area covered, percentage
thickness, percentage of specimens with smooth surface (ICRS 3), percentage of specimens with superior matrix (ICRS 2 and 3), and per-
centage of specimens with superior cell distribution (ICRS 2 and 3). *Indicates P< 0.05.toward worsening surface, matrix, and cell distribution for
the BMP-7 treatment group, however, these differences
did not reach signiﬁcance (Fig. 7).
COMBINATION OF MICROFRACTURE WITH BMP-7 IN A COLLA-
GEN SPONGE (COMBINATION TREATMENT) VS MICROFRAC-
TURE ALONE (HYPOTHESIS 3)
The combination treatment induced a statistically signiﬁ-
cant improvement in both the quantity and quality of repairtissue compared with microfracture alone. There was an in-
crease in percentage surface area covered (60% vs 50%,
P¼ 0.014). The combination treatment group had the
same percentage thickness as the microfracture group
(60% vs 61%, NS). The combination treatment and micro-
fracture both resulted in predominantly smooth surface
(81% vs 69%, NS). The combination treatment resulted in
signiﬁcantly improved matrix and cell distribution compared
with microfracture alone. The combination treatment re-
sulted in signiﬁcantly more samples with superior matrixFig. 9. Comparison of the combination treatment with BMP-7 (hypothesis 4). Comparison of the combination treatment group (microfracture
with BMP-7 in a collagen sponge) with the BMP-7 single treatment group for percentage surface area covered, percentage thickness, percent-
age of specimens with smooth surface (ICRS 3), percentage of specimens with superior matrix (ICRS 2 and 3), and percentage of specimens
with superior cell distribution (ICRS 2 and 3). **Indicates P< 0.01; ***indicates P< 0.001.
1133Osteoarthritis and Cartilage Vol. 14, No. 11Fig. 10. Comparison of the combination treatment with controls. Comparison of the combination treatment group (microfracture with BMP-7 in
a collagen sponge) with the control defect group for percentage surface area covered, percentage thickness, percentage of specimens with
smooth surface (ICRS 3), percentage of specimens with superior matrix (ICRS 2 and 3), and percentage of specimens with superior cell dis-
tribution (ICRS 2 and 3). *Indicates P< 0.05; ***indicates P< 0.001.(81% vs 38%, P¼ 0.048). Signiﬁcantly more samples from
the combination treatment group had superior cell distribu-
tion compared with the microfracture alone group (69% vs
19%, P¼ 0.019) (Fig. 8).
COMBINATION OF MICROFRACTURE WITH BMP-7 IN A
COLLAGEN SPONGE (COMBINATION TREATMENT) VS BMP-7
ALONE (HYPOTHESIS 4)
The combination group had more and better repair tissue
compared to the BMP-7 group. There was an increase in the
percentage surface area covered (60% vs 31%, P<
0.0001), as well as the percentage thickness (60% vs
34%, P¼ 0.0009). The combination treatment also resulted
in signiﬁcant improvements in surface, matrix, and cell distri-
bution. The samples with the combination treatment were
predominantly smooth, while few were smooth with BMP-7
alone (81% vs 8%, P¼ 0.0005). There were signiﬁcantly
more samples with superior matrix for the combination treat-
ment compared with BMP-7 alone (81% vs 8%, P¼ 0.0005).
Signiﬁcantly more samples receiving the combination treat-
ment also had superior cell distribution compared with
BMP-7 alone (69% vs 8%, P¼ 0.009) (Fig. 9). The combina-
tion group also had similar improvements relative to the con-
trol group (Fig. 10).
EFFECT OF THE COLLAGEN SPONGE CARRIER:
COMBINATION TREATMENT VS MICROFRACTURE PLUS
COLLAGEN SPONGE
In order to assess the effect of the collagen sponge used
as a carrier for BMP-7, we compared the combination treat-
ment (microfracture and BMP-7 in a collagen sponge) with
microfracture plus collagen sponge alone. Both treatments
had similar percentage surface area covered (60% vs
64%, NS), but the combination treatment led to thicker re-
pair tissue (60% vs 46%, P¼ 0.044). The repair tissue
was mostly smooth for both groups (81% vs 56%, NS).The combination treatment group had signiﬁcantly greater
proportions of superior matrix (81% vs 25%, P¼ 0.0038)
and superior cell distribution (69% vs 12%, P¼ 0.0032).
Therefore, the sponge carrier likely contributed to the in-
crease in surface area of repair tissue without improving tis-
sue thickness, matrix, or cell distribution.
Discussion
While both microfracture and BMP-7 treatment alone in-
creased the amount of repair tissue, only the combination
of treatments led to improvements in the matrix and cell dis-
tribution of the repair tissue. The repair tissue in all ﬁve treat-
ment groups hadnormal cell population viability, subchondral
bone, and cartilage mineralization. Both microfracture and
the combination treatment improved the surface of the repair
tissue. The ability of microfracture alone to improve the quan-
tity of repair tissue without greatly affecting its quality is con-
sistent with previous equine studies21. These results suggest
that these two treatments act synergistically, with microfrac-
ture playing the predominant role in increasing the amount
of repair tissue, andBMP-7 enhancing the quality of repair tis-
sue relative to microfracture alone. However, despite the
improvements in quantity and quality of repair tissue, the
combination treatment did not lead to either complete ﬁlling
of the defects or completely normal hyaline articular cartilage.
One limitation of this study is that the application of solu-
ble BMP-7 directly to a chondral defect is not equivalent to
the application of BMP-7 adsorbed onto a collagen sponge.
The latter form likely has a longer duration of action22.
Therefore, the BMP-7 single treatment group may not be
the optimal control for the effects of the morphogen. This
may explain the lack of improvement in the histological fea-
tures in this group relative to the control defect group. We
elected not to include a collagen sponge in the BMP-7
single treatment group since a sponge would probably not
remain stationary within a shallow chondral defect (less
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a loose body in the joint. In contrast, sponges that were
press-ﬁt into microfracture holes remained securely in place
even with joint movement.
The optimal method ofmorphogen delivery for cartilage re-
pair is unclear. Multiple matrices have been used as carriers
for soluble factors. In addition to serving as carriers, these
matricesmay also have biological effects. The type I collagen
sponge used in this study increased the surface area of repair
tissue without improving either thickness or histological char-
acteristics. Type I collagen also has been successfully used
as a carrier to deliver BMPs to osteochondral defects in ani-
mal models. BMP-2 adsorbed onto a type I collagen sponge
enhanced healing of osteochondral lesions in rabbits22, while
BMP-7 combined with particulate type I collagen led to hya-
line-like repair of osteochondral lesions in dogs23. In both of
these studies, the defects extended into the subchondral
bone and provided deep recesses (3 mm) that held the ap-
pliedmatrices. In contrast, the full-thickness chondral lesions
in our model, like those commonly found clinically, are signif-
icantly shallower (less than 0.4 mm in the current study;
Fig. 5). Full-thickness articular cartilage defects would not
hold insoluble matrices as efﬁciently as deeper osteochon-
dral defects. Microfracture allowed us to overcome this by
providing focal deeppockets intowhich sponges could be se-
curely press-ﬁt. Another method for the treatment of shallow
cartilage defects is the delivery of morphogens using a solu-
ble, adherent, self-gelling carrier. For example, in miniature
pigs, delivery of transforming growth factor-b1 in either a ﬁbrin
or gelatin matrix led to the ﬁlling of partial-thickness chondral
defects with cartilage-like tissue24,25. In contrast to marrow
stimulation, this treatment relies on the recruitment ofmesen-
chymal repair cells from the synovium. The indications for
and relative efﬁcacy of these two approaches must still be
determined.
The timing of morphogen administration also affects heal-
ing. In contrast to our results with a single application of
soluble factor, prolonged intra-articular administration of
soluble BMP-7 improved both the quality and quantity of re-
pair tissue in a sheep model of cartilage injury19. The differ-
ences from our results likely represent differences in the
duration of morphogen treatment. In the sheep study,
a mini-osmotic pump was implanted in the distal femur
and was used to deliver soluble BMP-7 into the knee over
2 weeks. This lengthy treatment may enhance the diff-
erentiation of cells as well as help them maintain their cho-
ndrocytic phenotype, thereby improving the quality of repair
tissue. However, implantation of an osmotic pump has more
morbidity than microfracture, and would require a second
surgery for pump removal.
Another limitation of this study is that the clear histological
improvements seen in the combination treatment group
may not lead to improved durability, mechanical properties,
or function of the repair tissue. Although the repair tissue
showed few signs of degeneration at sacriﬁce at 24 weeks,
progressive deterioration might be seen at later time points.
For example, in a study of osteochondral defects in both
skeletally immature and mature rabbits, degenerative
changes in the repair tissue increased in both frequency
and severity from 12 to 48 weeks6. Longer follow-up is nec-
essary to determine the ultimate fate of the patellofemoral
joints as well as of the repair tissue generated by microfrac-
ture and BMP-7.
The results of this study may not be generalizable to car-
tilage injuries in skeletally mature individuals, since the abil-
ity of cartilage to respond to treatments depends on the age
of an individual. At the time of surgery, the animals in thisstudy were undergoing the ﬁnal stages of epiphyseal devel-
opment. Their femora were approximately 95% of adult
length and their articular cartilage contained a superﬁcial
tangential layer, a radial layer, a calciﬁed zone, and a dis-
tinct tidemark (Fig. 5; Ref.26). Sacriﬁce occurred after phys-
eal closure. A different response to microfracture and BMP-
7 may occur in individuals injured and treated after physeal
closure. However, in a study of osteochondral defects in
rabbits, 4- to 6-month-old, skeletally immature animals ex-
hibited a similar cellular and histological response as 7- to
12-month-old, skeletally mature animals6.
In summary, BMP-7 enhances the effects of microfrac-
ture in adolescent rabbits, leading to an improvement in
the quality and quantity of repair tissue generated. Since
articular cartilage injuries appear to be increasing among
skeletally immature patients27, the addition of BMP-7 in
a collagen sponge may improve the clinical outcomes
of young individuals undergoing microfracture. This com-
bined technique could be easily adopted into clinical prac-
tice, since, like microfracture alone, the combination of
treatments is a technically simple procedure with low
morbidity.
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